Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Alexandra Moran"'
Autor:
Karina Galoian, Victoria Dahl, Andres Perez, Carina Denny, Beatrice Becker, Anil Sedani, Alexandra Moran, Daniel Martinez, Aaron Hoyt, Jeffrey Brown
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100644- (2022)
Background: Previous studies showed that proline-rich polypeptide (PRP-1) is a ligand for innate immunity toll-like receptors (TLR), and an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1) which induces the death of chondrosarcoma ca
Externí odkaz:
https://doaj.org/article/2825b92533994940a1f16f292c7cdc1d
Autor:
Baird, Alexandra Moran, Aday, Aaron W., Sullivan, Alexander E., Street, Tiffany, Barrett, Tyler W., Collins, Sean P., Stubblefield, William B., DNP, Megan M. Shifrin, Beckman, Joshua A.
Publikováno v:
In Journal of Vascular Nursing September 2024 42(3):208-212
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruth Alexandra Moran
Publikováno v:
Visual Inquiry. 9:27-44
This article examines the recent intense public interest in Dublin street art collective Subset’s urban painting, which co-opts the language, practices and attitude of graffiti culture as brand narrative, producing a commodity from their portrayal
Autor:
Alexandra Moran, Caroline J. Granger, Anil Sedani, Shannon Saigh, Beatrice Becker, Sheila A. Conway, Jeffrey Brown, Karina Galoian, Aaron K. Hoyt
Publikováno v:
Molecular Medicine Reports
Chondrosarcoma is a malignant bone neoplasm that is refractory to chemotherapy and radiation. With no current biological treatments, mutilating surgical resection is the only effective treatment. Proline rich polypeptide 1 (PRP‑1), which is a 15‑
Autor:
Caroline J. Granger, Liu Zhao-Ju, Sheila A. Conway, Jeffrey Brown, Anil Sedani, Karina Galoian, Aaron K. Hoyt, Juan Pretell, Shannon Saigh, Marzenna Blonska, Alexandra Moran
Publikováno v:
Oncology Reports. 44:393-403
Chondrosarcoma is the second most common primary malignant bone tumor and is resistant to chemotherapy and radiation. Inadequate treatment response and poor prognosis requires novel therapeutic approaches. Proline‑rich polypeptide‑1 (PRP‑1), sy
Autor:
Alexandra Moran, Katherine Hays
Publikováno v:
Vascular Medicine. 24:571-574
Autor:
Aaron K. Hoyt, Alexandra Moran, Anil Sedani, Karina Galoian, Jeffrey Brown, Shannon Saigh, Caroline J. Granger
Publikováno v:
Oncology Reports
Chondrosarcomas are malignant bone tumors refractory to chemotherapy and radiation treatment; thus, novel therapeutic strategies are required. Proline‑rich polypeptide 1 (PRP‑1) has previously demonstrated antitumor properties in chondrosarcoma.
Autor:
Nipun B. Merchant, Omar Picado, Alexandra Moran, Danny Sleeman, Fiorella Pendola, Lorena Flor Ramos, Vikas Dudeja, Danny Yakoub
Publikováno v:
Journal of Surgical Oncology. 119:455-463
Hepatocellular carcinoma (HCC) has a recurrence rate of up to 70% in 5 years after resection, detrimentally lowering survival. The role of adjuvant therapy remains controversial; therefore, the aim of this study was to evaluate the disease-free and o
Publikováno v:
Journal of Vascular Nursing
Coronavirus disease of 2019 poses significant risks for patients with vascular disease. Telemedicine can help clinicians provide care for patients with vascular disease while adhering to social-distancing guidelines. In this article, we review the co